{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AMGM5 cells", "Newcastle disease virus (NDV)", "PVA", "REF cells", "combination therapy", "cytotoxicity", "glioblastoma", "polylactic-co-glycolic acid (PLGA)", "temozolomide (TMZ)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36144488", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "06"}], "Language": ["eng"], "ELocationID": ["5757", "10.3390/molecules27185757"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "18", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "06"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.", "Abstract": {"AbstractText": ["Glioblastoma multiforme (GBM) is considered to be one of the most serious version of primary malignant tumors. Temozolomide (TMZ), an anti-cancer drug, is the most common chemotherapeutic agent used for patients suffering from GBM. However, due to its inherent instability, short biological half-life, and dose-limiting characteristics, alternatives to TMZ have been sought. In this study, the TMZ-loaded PLGA nanoparticles were prepared by employing the emulsion solvent evaporation technique. The prepared TMZ-PLGA-NPs were characterized using FT-IR, zeta potential analyses, XRD pattern, particle size estimation, TEM, and FE-SEM observations. The virotherapy, being safe, selective, and effective in combating cancer, was employed, and TMZ-PLGA-NPs and oncolytic Newcastle Disease Virus (NDV) were co-administered for the purpose. An AMHA1-attenuated strain of NDV was propagated in chicken embryos, and the virus was titrated in Vero-slammed cells to determine the infective dose. The in vitro cytotoxic effects of the TMZ, NDV, and the TMZ-PLGA-NPs against the human glioblastoma cancer cell line, AMGM5, and the normal cell line of rat embryo fibroblasts (REFs) were evaluated. The synergistic effects of the nano-formulation and viral strain combined therapy was observed on the cell lines in MTT viability assays, together with the Chou-Talalay tests. The outcomes of the in vitro investigation revealed that the drug combinations of NDV and TMZ, as well as NDV and TMZ-PLGA-NPs exerted the synergistic enhancements of the antitumor activity on the AMGM5 cell lines. The effectiveness of both the mono, and combined treatments on the capability of AMGM5 cells to form colonies were also examined with crystal violet dyeing tests. The morphological features, and apoptotic reactions of the treated cells were investigated by utilizing the phase-contrast inverted microscopic examinations, and acridine orange/propidium iodide double-staining tests. Based on the current findings, the potential for the use of TMZ and NDV as part of a combination treatment of GBM is significant, and may work for patients suffering from GBM."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq."}], "LastName": "Kadhim", "ForeName": "Zahraa A", "Initials": "ZA"}, {"Identifier": ["0000-0001-6388-3849"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Biotechnology, Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq."}], "LastName": "Sulaiman", "ForeName": "Ghassan M", "Initials": "GM"}, {"Identifier": ["0000-0002-2699-1514"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Therapy, Iraqi Centre for Cancer and Medical Genetics Research, Mustansiriyah University, Baghdad 14022, Iraq."}], "LastName": "Al-Shammari", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0003-0185-0149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Riaz A", "Initials": "RA"}, {"Identifier": ["0000-0001-8148-0138"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine and Medical Sciences, Qassim University, Unaizah 51911, Saudi Arabia."}], "LastName": "Al Rugaie", "ForeName": "Osamah", "Initials": "O"}, {"Identifier": ["0000-0003-2896-6790"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy, Al-Azhar University, Cairo 11371, Egypt."}], "LastName": "Mohammed", "ForeName": "Hamdoon A", "Initials": "HA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Emulsions"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "36015-30-2", "NameOfSubstance": "Propidium"}, {"RegistryNumber": "F30N4O6XVV", "NameOfSubstance": "Acridine Orange"}, {"RegistryNumber": "J4Z741D6O5", "NameOfSubstance": "Gentian Violet"}, {"RegistryNumber": "YF1K15M17Y", "NameOfSubstance": "Temozolomide"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acridine Orange"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Chick Embryo"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Emulsions"}, {"QualifierName": [], "DescriptorName": "Gentian Violet"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Glioblastoma"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Newcastle disease virus"}, {"QualifierName": [], "DescriptorName": "Oncolytic Viruses"}, {"QualifierName": [], "DescriptorName": "Propidium"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Solvents"}, {"QualifierName": [], "DescriptorName": "Spectroscopy, Fourier Transform Infrared"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Temozolomide"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bower J.E., Asher A., Garet D., Petersen L., Ganz P.A., Irwin M.R., Cole S.W., Hurvitz S.A., Crespi C.M. Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer. Cancer. 2019;125:633\u2013641. doi: 10.1002/cncr.31827.", "ArticleIdList": ["10.1002/cncr.31827", "PMC6373488", "30561795"]}, {"Citation": "Mula-Hussain L., Alabedi H., Al-Alloosh F., Alharganee A. Handbook of Healthcare in the Arab World. Springer; Berlin/Heidelberg, Germany: 2021. Cancer in war-torn countries: Iraq as an example; pp. 481\u2013494."}, {"Citation": "Al Alwan N.A.S. Cancer in the Arab World. Springer; Berlin/Heidelberg, Germany: 2022. General Oncology Care in Iraq; pp. 63\u201382."}, {"Citation": "Mutar M.T., Goyani M.S., Had A.M., Mahmood A.S. Pattern of presentation of patients with breast cancer in Iraq in 2018: A cross-sectional study. J. Glob. Oncol. 2019;5:1\u20136. doi: 10.1200/JGO.19.00041.", "ArticleIdList": ["10.1200/JGO.19.00041", "PMC6882514", "31721627"]}, {"Citation": "Bai H. Integrative Omic Analysis of IDH1-Mutant Glioma Malignant Progression. Yale University; New Haven, CT, USA: 2016."}, {"Citation": "Ramalho M.J., Andrade S., Coelho M.\u00c1.N., Loureiro J.A., Pereira M.C. Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy. Eur. J. Pharm. Biopharm. 2019;136:156\u2013163. doi: 10.1016/j.ejpb.2019.01.015.", "ArticleIdList": ["10.1016/j.ejpb.2019.01.015", "30682492"]}, {"Citation": "Shergalis A., Bankhead A., Luesakul U., Muangsin N., Neamati N. Current challenges and opportunities in treating glioblastoma. Pharmacol. Rev. 2018;70:412\u2013445. doi: 10.1124/pr.117.014944.", "ArticleIdList": ["10.1124/pr.117.014944", "PMC5907910", "29669750"]}, {"Citation": "Bahjat H.H., Ismail R.A., Sulaiman G.M., Mohammed H.A., Al-Omar M., Mohammed S.A.A., Khan R.A. Preparation of iron oxide and titania-based composite, core-shell populated, nanoparticulates material by two-step LASER ablation in aqueous media as antimicrobial and anticancer agents. Bioinorg. Chem. Appl. 2022;2022:1854473. doi: 10.1155/2022/1854473.", "ArticleIdList": ["10.1155/2022/1854473", "PMC8807045", "35116061"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.d.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnology. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Ramalho M.J., Pereira M.C. Preparation and characterization of polymeric nanoparticles: An interdisciplinary experiment. J. Chem. Educ. 2016;93:1446\u20131451. doi: 10.1021/acs.jchemed.5b00837.", "ArticleIdList": ["10.1021/acs.jchemed.5b00837"]}, {"Citation": "Tang C.-M., Tian Y.-H., Hsu S.-H. Poly (vinyl alcohol) nanocomposites reinforced with bamboo charcoal nanoparticles: Mineralization behavior and characterization. Materials. 2015;8:4895\u20134911. doi: 10.3390/ma8084895.", "ArticleIdList": ["10.3390/ma8084895", "PMC5455495", "28793480"]}, {"Citation": "Mai P.L., Best A.F., Peters J.A., DeCastro R.M., Khincha P.P., Loud J.T., Bremer R.C., Rosenberg P.S., Savage S.A. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer. 2016;122:3673\u20133681. doi: 10.1002/cncr.30248.", "ArticleIdList": ["10.1002/cncr.30248", "PMC5115949", "27496084"]}, {"Citation": "Shi J., Kantoff P.W., Wooster R., Farokhzad O.C. Cancer nanomedicine: Progress, challenges and opportunities. Nat. Rev. Cancer. 2017;17:20\u201337. doi: 10.1038/nrc.2016.108.", "ArticleIdList": ["10.1038/nrc.2016.108", "PMC5575742", "27834398"]}, {"Citation": "Al-Shammari A.M., Al-Nassrawei H.A., Kadhim A.M.A. Isolation and sero-diagnosis of Newcastle disease virus infection in human and chicken poultry flocks in three cities of middle Euphrates. Kufa J. Vet. Med. Sci. 2014;5:16\u201321."}, {"Citation": "Paul R., Kulkarni P., Ganesh N. Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture. J. Exp. Ther. Oncol. 2011;9:221\u2013230.", "ArticleIdList": ["22070054"]}, {"Citation": "Kaufman H.L., Kohlhapp F.J., Zloza A. Oncolytic viruses: A new class of immunotherapy drugs. Nat. Rev. Drug Discov. 2015;14:642\u2013662. doi: 10.1038/nrd4663.", "ArticleIdList": ["10.1038/nrd4663", "PMC7097180", "26323545"]}, {"Citation": "Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. Int. J. Oncol. 2019;54:407\u2013419.", "ArticleIdList": ["PMC6317661", "30570109"]}, {"Citation": "Bai Y., Hui P., Du X., Su X. Updates to the antitumor mechanism of oncolytic virus. Thorac. Cancer. 2019;10:1031\u20131035. doi: 10.1111/1759-7714.13043.", "ArticleIdList": ["10.1111/1759-7714.13043", "PMC6501037", "30900824"]}, {"Citation": "Prinsloo S., Novy D., Driver L., Lyle R., Ramondetta L., Eng C., Lopez G., Li Y., Cohen L. The long-term impact of neurofeedback on symptom burden and interference in patients with chronic chemotherapy-induced neuropathy: Analysis of a randomized controlled trial. J. Pain Symptom Manag. 2018;55:1276\u20131285. doi: 10.1016/j.jpainsymman.2018.01.010.", "ArticleIdList": ["10.1016/j.jpainsymman.2018.01.010", "29421164"]}, {"Citation": "Al-Shammari A.M., Ismaeel F.E., Salih S.M., Yaseen N.Y. Live attenuated measles virus vaccine therapy for locally established malignant glioblastoma tumor cells. Oncolytic Virotherapy. 2014;3:57. doi: 10.2147/OV.S59037.", "ArticleIdList": ["10.2147/OV.S59037", "PMC4918365", "27512663"]}, {"Citation": "Al-Shammari A.M., Rameez H., Al-Taee M.F. Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy. Oncolytic Virotherapy. 2016;5:27. doi: 10.2147/OV.S95250.", "ArticleIdList": ["10.2147/OV.S95250", "PMC4996254", "27579294"]}, {"Citation": "Parsons D.W., Roy A., Yang Y., Wang T., Scollon S., Bergstrom K., Kerstein R.A., Gutierrez S., Petersen A.K., Bavle A. Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol. 2016;2:616\u2013624. doi: 10.1001/jamaoncol.2015.5699.", "ArticleIdList": ["10.1001/jamaoncol.2015.5699", "PMC5471125", "26822237"]}, {"Citation": "Martin C. Oncolytic viruses: Treatment and implications for patients with gliomas. Clin. J. Oncol. Nurs. 2017;21:60\u201364. doi: 10.1188/17.CJON.S2.60-64.", "ArticleIdList": ["10.1188/17.CJON.S2.60-64", "28315557"]}, {"Citation": "Bai Y., Chen Y., Hong X., Liu X., Su X., Li S., Dong X., Zhao G., Li Y. Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo. Scintific Rep. 2018;8:11470. doi: 10.1038/s41598-018-29929-y.", "ArticleIdList": ["10.1038/s41598-018-29929-y", "PMC6068118", "30065314"]}, {"Citation": "Dimitrov K.M., Abolnik C., Afonso C.L., Albina E., Bahl J., Berg M., Briand F.-X., Brown I.H., Choi K.-S., Chvala I. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect. Genet. Evol. 2019;74:103917. doi: 10.1016/j.meegid.2019.103917.", "ArticleIdList": ["10.1016/j.meegid.2019.103917", "PMC6876278", "31200111"]}, {"Citation": "Tsai Y.-M., Chien C.-F., Lin L.-C., Tsai T.-H. Curcumin and its nano-formulation: The kinetics of tissue distribution and blood brain barrier penetration. Int. J. Pharm. 2011;416:331\u2013338. doi: 10.1016/j.ijpharm.2011.06.030.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Patil R., Portilla-Arias J., Ding H., Inoue S., Konda B., Hu J., Wawrowsky K.A., Shin P.K., Black K.L., Holler E. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly (\u03b2-L-malic acid) Pharm. Res. 2010;27:2317\u20132329. doi: 10.1007/s11095-010-0091-0.", "ArticleIdList": ["10.1007/s11095-010-0091-0", "PMC2952070", "20387095"]}, {"Citation": "del Burgo L.S., Hern\u00e1ndez R.M., Orive G., Pedraz J.L. Nanotherapeutic approaches for brain cancer management. Nanomed. Nanotechnol. Biol. Med. 2014;10:e905\u2013e919. doi: 10.1016/j.nano.2013.10.001.", "ArticleIdList": ["10.1016/j.nano.2013.10.001", "24135564"]}, {"Citation": "Zhang D., Tian A., Xue X., Wang M., Qiu B., Wu A. The effect of temozolomide/poly (lactide-co-glycolide)(PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior. Int. J. Mol. Sci. 2012;13:1109\u20131125. doi: 10.3390/ijms13011109.", "ArticleIdList": ["10.3390/ijms13011109", "PMC3269741", "22312307"]}, {"Citation": "Huang G., Zhang N., Bi X., Dou M. Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity. Int. J. Pharm. 2008;355:314\u2013320. doi: 10.1016/j.ijpharm.2007.12.013.", "ArticleIdList": ["10.1016/j.ijpharm.2007.12.013", "18255242"]}, {"Citation": "Jain D.S., Athawale R.B., Bajaj A.N., Shrikhande S.S., Goel P.N., Nikam Y., Gude R.P. Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles. DARU J. Pharm. Sci. 2014;22:1\u20139. doi: 10.1186/2008-2231-22-18.", "ArticleIdList": ["10.1186/2008-2231-22-18", "PMC3896810", "24410831"]}, {"Citation": "Schwendy M., Unger R.E., Bonn M., Parekh S.H. Automated cell segmentation in FIJI\u00ae using the DRAQ5 nuclear dye. BMC Bioinform. 2019;20:1\u20139. doi: 10.1186/s12859-019-2602-2.", "ArticleIdList": ["10.1186/s12859-019-2602-2", "PMC6339324", "30658582"]}, {"Citation": "Vergara-Jaque A., Comer J., Monsalve L., Gonzalez-Nilo F.D., Sandoval C. Computationally efficient methodology for atomic-level characterization of dendrimer\u2013drug complexes: A comparison of amine-and acetyl-terminated PAMAM. J. Phys. Chem. B. 2013;117:6801\u20136813. doi: 10.1021/jp4000363.", "ArticleIdList": ["10.1021/jp4000363", "23642174"]}, {"Citation": "Gelperina S., Maksimenko O., Khalansky A., Vanchugova L., Shipulo E., Abbasova K., Berdiev R., Wohlfart S., Chepurnova N., Kreuter J. Drug delivery to the brain using surfactant-coated poly (lactide-co-glycolide) nanoparticles: Influence of the formulation parameters. Eur. J. Pharm. Biopharm. 2010;74:157\u2013163. doi: 10.1016/j.ejpb.2009.09.003.", "ArticleIdList": ["10.1016/j.ejpb.2009.09.003", "19755158"]}, {"Citation": "Rodriguez de Anda D.A., Ohannesian N., Martirosyan K.S., Chew S.A. Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma. J. Biomed. Mater. Res. Part B Appl. Biomater. 2019;107:2317\u20132324. doi: 10.1002/jbm.b.34324.", "ArticleIdList": ["10.1002/jbm.b.34324", "PMC6697243", "30767394"]}, {"Citation": "Lopes I.C., de Oliveira S.C.B., Oliveira-Brett A.M. Temozolomide chemical degradation to 5-aminoimidazole-4-carboxamide\u2013electrochemical study. J. Electroanal. Chem. 2013;704:183\u2013189. doi: 10.1016/j.jelechem.2013.07.011.", "ArticleIdList": ["10.1016/j.jelechem.2013.07.011"]}, {"Citation": "Sahu S.K., Mallick S.K., Santra S., Maiti T.K., Ghosh S.K., Pramanik P. In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J. Mater. Sci. Mater. Med. 2010;21:1587\u20131597. doi: 10.1007/s10856-010-3998-4.", "ArticleIdList": ["10.1007/s10856-010-3998-4", "20111985"]}, {"Citation": "Dhas D.A. Vibrational spectra and natural bond orbital analysis of temozolomide acid. J. Appl. Sci. Eng. Methodol. 2016;2:322\u2013325."}, {"Citation": "Arasoglu T., Derman S., Mansuroglu B. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods. Nanotechnology. 2015;27:25103. doi: 10.1088/0957-4484/27/2/025103.", "ArticleIdList": ["10.1088/0957-4484/27/2/025103", "26629915"]}, {"Citation": "Barone G., Bartoli L., Belfiore C.M., Crupi V., Longo F., Majolino D., Mazzoleni P., Venuti V. Comparison between TOF-ND and XRD quantitative phase analysis of ancient potteries. J. Anal. At. Spectrom. 2011;26:1060\u20131067. doi: 10.1039/c0ja00224k.", "ArticleIdList": ["10.1039/c0ja00224k"]}, {"Citation": "Gu W., Fan R., Quan J., Cheng Y., Wang S., Zhang H., Zheng A., Song S. Intracranial In Situ Thermosensitive Hydrogel Delivery of Temozolomide Accomplished by PLGA\u2013PEG\u2013PLGA Triblock Copolymer Blending for GBM Treatment. Polymers. 2022;14:3368. doi: 10.3390/polym14163368.", "ArticleIdList": ["10.3390/polym14163368", "PMC9413267", "36015626"]}, {"Citation": "Assefi M., Onsory K., Iranbakhsh A. Understanding the toxicity of nanotubes and nanoparticles in the environment: Are nanotubes and nanoparticles safe. Asian J. Od Pharm. Technol. Innoviation. 2021;9:5\u201310."}, {"Citation": "Jain D., Bajaj A., Athawale R., Shrikhande S., Goel P.N., Nikam Y., Gude R., Patil S., Prashant Raut P. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: Development, characterization and in vivo studies. Drug Deliv. 2016;23:989\u20131006. doi: 10.3109/10717544.2014.926574.", "ArticleIdList": ["10.3109/10717544.2014.926574", "25026415"]}, {"Citation": "Win K.Y., Feng S.-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26:2713\u20132722. doi: 10.1016/j.biomaterials.2004.07.050.", "ArticleIdList": ["10.1016/j.biomaterials.2004.07.050", "15585275"]}, {"Citation": "Tang X., Cai S., Zhang R., Liu P., Chen H., Zheng Y., Sun L. Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment. Nanoscale Res. Lett. 2013;8:420. doi: 10.1186/1556-276X-8-420.", "ArticleIdList": ["10.1186/1556-276X-8-420", "PMC3874754", "24134303"]}, {"Citation": "Saraiva C., Pra\u00e7a C., Ferreira R., Santos T., Ferreira L., Bernardino L. Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases. J. Control. Release. 2016;235:34\u201347. doi: 10.1016/j.jconrel.2016.05.044.", "ArticleIdList": ["10.1016/j.jconrel.2016.05.044", "27208862"]}, {"Citation": "Dembek M., Bocian S., Buszewski B. Solvent Influence on Zeta Potential of Stationary Phase\u2014Mobile Phase Interface. Molecules. 2022;27:968. doi: 10.3390/molecules27030968.", "ArticleIdList": ["10.3390/molecules27030968", "PMC8839144", "35164234"]}, {"Citation": "Sahana D.K., Mittal G., Bhardwaj V., Kumar M.N.V.R. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J. Pharm. Sci. 2008;97:1530\u20131542. doi: 10.1002/jps.21158.", "ArticleIdList": ["10.1002/jps.21158", "17722098"]}, {"Citation": "Derman S. Caffeic acid phenethyl ester loaded PLGA nanoparticles: Effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J. Nanomater. 2015;2015:341848. doi: 10.1155/2015/341848.", "ArticleIdList": ["10.1155/2015/341848"]}, {"Citation": "Wohlfart S., Gelperina S., Kreuter J. Transport of drugs across the blood\u2013brain barrier by nanoparticles. J. Control. Release. 2012;161:264\u2013273. doi: 10.1016/j.jconrel.2011.08.017.", "ArticleIdList": ["10.1016/j.jconrel.2011.08.017", "21872624"]}, {"Citation": "Fornaguera C., Solans C. Characterization of polymeric nanoparticle dispersions for biomedical applications: Size, surface charge and stability. Pharm. Nanotechnol. 2018;6:147\u2013164. doi: 10.2174/2211738506666180706121515.", "ArticleIdList": ["10.2174/2211738506666180706121515", "29984674"]}, {"Citation": "Suvarna S., Das U., Kc S., Mishra S., Sudarshan M., Saha K.D., Dey S., Chakraborty A., Narayana Y. Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate. PLoS ONE. 2017;12:e0178202. doi: 10.1371/journal.pone.0178202.", "ArticleIdList": ["10.1371/journal.pone.0178202", "PMC5459428", "28582426"]}, {"Citation": "Dangi R.S., Shakya S. Preparation, optimization and characterization of PLGA nanoparticle. Int. J. Pharm. Life Sci. 2013;4:2810\u20132818."}, {"Citation": "Lu B., Lv X., Le Y. Chitosan-modified PLGA nanoparticles for control-released drug delivery. Polymers. 2019;11:304. doi: 10.3390/polym11020304.", "ArticleIdList": ["10.3390/polym11020304", "PMC6419218", "30960288"]}, {"Citation": "Souza T.G.F., Ciminelli V.S.T., Mohallem N.D.S. A comparison of TEM and DLS methods to characterize size distribution of ceramic nanoparticles. J. Phys. Conf. Ser. 2016;733:12039. doi: 10.1088/1742-6596/733/1/012039.", "ArticleIdList": ["10.1088/1742-6596/733/1/012039"]}, {"Citation": "Pr\u00fcger B., Eppmann P., Donath E., Gimsa J. Measurement of inherent particle properties by dynamic light scattering: Introducing electrorotational light scattering. Biophys. J. 1997;72:1414\u20131424. doi: 10.1016/S0006-3495(97)78788-5.", "ArticleIdList": ["10.1016/S0006-3495(97)78788-5", "PMC1184524", "9138587"]}, {"Citation": "S\u00e1nchez-L\u00f3pez E., Ettcheto M., Egea M.A., Espina M., Cano A., Calpena A.C., Camins A., Carmona N., Silva A.M., Souto E.B., et al. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: In vitro and in vivo characterization. J. Nanobiotechnology. 2018;16:32. doi: 10.1186/s12951-018-0356-z.", "ArticleIdList": ["10.1186/s12951-018-0356-z", "PMC5870370", "29587747"]}, {"Citation": "Lam F.C., Morton S.W., Wyckoff J., Vu Han T.L., Hwang M.K., Maffa A., Balkanska-Sinclair E., Yaffe M.B., Floyd S.R., Hammond P.T. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Nat. Commun. 2018;9:1991. doi: 10.1038/s41467-018-04315-4.", "ArticleIdList": ["10.1038/s41467-018-04315-4", "PMC5959860", "29777137"]}, {"Citation": "Kumari S., Ahsan S.M., Kumar J.M., Kondapi A.K., Rao N.M. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433) Sci. Rep. 2017;7:6602. doi: 10.1038/s41598-017-06888-4.", "ArticleIdList": ["10.1038/s41598-017-06888-4", "PMC5529576", "28747713"]}, {"Citation": "Pham T.T., Nguyen T.T., Pathak S., Regmi S., Nguyen H.T., Tran T.H., Yong C.S., Kim J.O., Park P., Park M.H. Tissue adhesive FK506\u2013loaded polymeric nanoparticles for multi\u2013layered nano\u2013shielding of pancreatic islets to enhance xenograft survival in a diabetic mouse model. Biomaterials. 2018;154:182\u2013196. doi: 10.1016/j.biomaterials.2017.10.049.", "ArticleIdList": ["10.1016/j.biomaterials.2017.10.049", "29128846"]}, {"Citation": "Duwa R., Banstola A., Emami F., Jeong J.-H., Lee S., Yook S. Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells. J. Drug Deliv. Sci. Technol. 2020;60:101928. doi: 10.1016/j.jddst.2020.101928.", "ArticleIdList": ["10.1016/j.jddst.2020.101928"]}, {"Citation": "Holy C.E., Dang S.M., Davies J.E., Shoichet M.S. In vitro degradation of a novel poly (lactide-co-glycolide) 75/25 foam. Biomaterials. 1999;20:1177\u20131185. doi: 10.1016/S0142-9612(98)00256-7.", "ArticleIdList": ["10.1016/S0142-9612(98)00256-7", "10395386"]}, {"Citation": "Baiti R.N., Ardhyananta H., El Kirat K. Effect of acidic and basic environment to the degradation behavior of PLGA nanocapsules for biomedical application. Adv. Mater. Res. 2015;1123:213\u2013216. doi: 10.4028/www.scientific.net/AMR.1123.213.", "ArticleIdList": ["10.4028/www.scientific.net/AMR.1123.213"]}, {"Citation": "Al-Shamery A., Yaseen N., Alwan M.J. Study the Antigenic modification of tumor cell surface by NDV infection. Iraqi J. Cancer. 2009;2:95\u2013100."}, {"Citation": "Al-Shammari A.M., Al-Hili Z.A., Yaseen N.Y. 647. Iraqi Newcastle disease virus virulent strain as cancer antiangiogenic agent. Molicular Ther. 2013;21:S247. doi: 10.1016/S1525-0016(16)34982-6.", "ArticleIdList": ["10.1016/S1525-0016(16)34982-6"]}, {"Citation": "Schirrmacher V. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance. Expert Opin. Biol. Ther. 2015;15:1757\u20131771. doi: 10.1517/14712598.2015.1088000.", "ArticleIdList": ["10.1517/14712598.2015.1088000", "26436571"]}, {"Citation": "Choi A.H., O\u2019Leary M.P., Fong Y., Chen N.G. From benchtop to bedside: A review of oncolytic virotherapy. Biomedicines. 2016;4:18. doi: 10.3390/biomedicines4030018.", "ArticleIdList": ["10.3390/biomedicines4030018", "PMC5344257", "28536385"]}, {"Citation": "Othman F., Ideris A., Motaleb G.H.R., Eshak Z.B.T., Rahmat A. Oncolytic effect of Newcastle disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh Med. J. 2010;12:17\u201324."}, {"Citation": "Kwan A., Winder N., Muthana M. Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances. Viruses. 2021;13:1128. doi: 10.3390/v13061128.", "ArticleIdList": ["10.3390/v13061128", "PMC8230950", "34208264"]}, {"Citation": "Suffness M. Assays related to cancer drug discovery. Methods plant Biochem. Assays Bioactivity. 1990;6:71\u2013133."}, {"Citation": "Al-Shammari A.M., Yaseen N., Alwan M.J. Immunology study for NDV treatment in mice bearing mammary adenocarcinoma tumor. J. Cancer Med. Genet. 2011;4:11\u201321."}, {"Citation": "Alonso M.M., Gomez-Manzano C., Bekele B.N., Yung W.K.A., Fueyo J. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007;67:11499\u201311504. doi: 10.1158/0008-5472.CAN-07-5312.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5312", "18089777"]}, {"Citation": "Ciccia A., Elledge S.J. The DNA damage response: Making it safe to play with knives. Molecular Cell. 2010;40:179\u2013204. doi: 10.1016/j.molcel.2010.09.019.", "ArticleIdList": ["10.1016/j.molcel.2010.09.019", "PMC2988877", "20965415"]}, {"Citation": "Borges H.L., Linden R., Wang J.Y.J. DNA damage-induced cell death: Lessons from the central nervous system. Cell Res. 2008;18:17\u201326. doi: 10.1038/cr.2007.110.", "ArticleIdList": ["10.1038/cr.2007.110", "PMC2626635", "18087290"]}, {"Citation": "Wang J.Y.J., Cho S.K. Coordination of repair, checkpoint, and cell death responses to DNA damage. Adv. Protein Chem. 2004;69:101\u2013135.", "ArticleIdList": ["15588841"]}, {"Citation": "Di Martino A., Kucharczyk P., Capakova Z., Humpolicek P., Sedlarik V. Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles. J. Nanoparticle Res. 2017;19:71. doi: 10.1007/s11051-017-3756-3.", "ArticleIdList": ["10.1007/s11051-017-3756-3", "PMC5313595", "28260965"]}, {"Citation": "Foucquier J., Guedj M. Analysis of drug combinations: Current methodological landscape. Pharmacol. Res. Perspect. 2015;3:e00149. doi: 10.1002/prp2.149.", "ArticleIdList": ["10.1002/prp2.149", "PMC4492765", "26171228"]}, {"Citation": "Al-Qubaisi M.S., Rasedee A., Flaifel M.H., Ahmad S.H.J., Hussein-Al-Ali S., Hussein M.Z., Eid E.E.M., Zainal Z., Saeed M., Ilowefah M. Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin. Int. Joural Nanomed. 2013;8:2497. doi: 10.2147/IJN.S42367.", "ArticleIdList": ["10.2147/IJN.S42367", "PMC3716602", "23885175"]}, {"Citation": "Hegi M.E., Liu L., Herman J.G., Stupp R., Wick W., Weller M., Mehta M.P., Gilbert M.R. Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J. Clin. Oncol. 2008;26:4189\u20134199. doi: 10.1200/JCO.2007.11.5964.", "ArticleIdList": ["10.1200/JCO.2007.11.5964", "18757334"]}, {"Citation": "Zhang J., Stevens M.F.G., Laughton C.A., Madhusudan S., Bradshaw T.D. Acquired resistance to temozolomide in glioma cell lines: Molecular mechanisms and potential translational applications. Oncology. 2010;78:103\u2013114. doi: 10.1159/000306139.", "ArticleIdList": ["10.1159/000306139", "20357518"]}, {"Citation": "Felsberg J., Thon N., Eigenbrod S., Hentschel B., Sabel M.C., Westphal M., Schackert G., Kreth F.W., Pietsch T., L\u00f6ffler M. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int. J. Cancer. 2011;129:659\u2013670. doi: 10.1002/ijc.26083.", "ArticleIdList": ["10.1002/ijc.26083", "21425258"]}, {"Citation": "Oike T., Suzuki Y., Sugawara K., Shirai K., Noda S., Tamaki T., Nagaishi M., Yokoo H., Nakazato Y., Nakano T. Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results. PLoS ONE. 2013;8:e78943. doi: 10.1371/journal.pone.0078943.", "ArticleIdList": ["10.1371/journal.pone.0078943", "PMC3827088", "24265731"]}, {"Citation": "Meng G., Xia M., Wang D., Chen A., Wang Y., Wang H., Yu D., Wei J. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells. Oncotarget. 2014;5:6365. doi: 10.18632/oncotarget.2219.", "ArticleIdList": ["10.18632/oncotarget.2219", "PMC4171636", "25051374"]}, {"Citation": "Szeber\u00e9nyi J., F\u00e1bi\u00e1n Z., T\u00f6r\u00f6csik B., Kiss K., Csatary L.K. Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells. Am. J. Ther. 2003;10:282\u2013288. doi: 10.1097/00045391-200307000-00008.", "ArticleIdList": ["10.1097/00045391-200307000-00008", "12845392"]}, {"Citation": "Sulaiman G.M., Jabir M.S., Hameed A.H. Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity. Artif. Cells Nanomed. Biotechnol. 2018;46:708\u2013720. doi: 10.1080/21691401.2018.1434661.", "ArticleIdList": ["10.1080/21691401.2018.1434661", "29383946"]}, {"Citation": "Yin H., Zhou Y., Wen C., Zhou C., Zhang W., Hu X., Wang L., You C., Shao J. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling. Oncol. Rep. 2014;32:1610\u20131616. doi: 10.3892/or.2014.3342.", "ArticleIdList": ["10.3892/or.2014.3342", "25050915"]}, {"Citation": "Zhang J., FG Stevens M., Bradshaw T.D. Temozolomide: Mechanisms of action, repair and resistance. Curr. Mol. Pharmacol. 2012;5:102\u2013114. doi: 10.2174/1874467211205010102.", "ArticleIdList": ["10.2174/1874467211205010102", "22122467"]}, {"Citation": "Agarwala S.S., Kirkwood J.M. Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma. Oncologist. 2000;5:144\u2013151. doi: 10.1634/theoncologist.5-2-144.", "ArticleIdList": ["10.1634/theoncologist.5-2-144", "10794805"]}, {"Citation": "Sharma A., Singh K., Almasan A. DNA Repair Protocols. Volume 920. Humana Press; Totowa, NJ, USA: 2012. Histone H2AX phosphorylation: A marker for DNA damage; pp. 613\u2013626.", "ArticleIdList": ["10.1007/978-1-61779-998-3_40", "22941631"]}, {"Citation": "Podhorecka M., Skladanowski A., Bozko P. H2AX phosphorylation: Its role in DNA damage response and cancer therapy. J. Nucleic Acids. 2010;2010:920161. doi: 10.4061/2010/920161.", "ArticleIdList": ["10.4061/2010/920161", "PMC2929501", "20811597"]}, {"Citation": "Mohammed H.A., Sulaiman G.M., Anwar S.S., Tawfeeq A.T., Khan R.A., Mohammed S.A.A., Al-Omar M.S., Alsharidah M., Rugaie O.A., Al-Amiery A.A. Quercetin against MCF7 and CAL51 breast cancer cell lines: Apoptosis, gene expression and cytotoxicity of nano-quercetin. Nanomedicine. 2021;16:1937\u20131961. doi: 10.2217/nnm-2021-0070.", "ArticleIdList": ["10.2217/nnm-2021-0070", "34431317"]}, {"Citation": "Salih R.H., Odisho S.M., Al-Shammari A.M., Ibrahim O.M.S. Antiviral effects of olea europaea leaves extract and interferon-beta on gene expression of newcastle disease virus. Adv. Anim. Vet. Sci. 2017;5:436\u2013445. doi: 10.17582/journal.aavs/2017/5.11.436.445.", "ArticleIdList": ["10.17582/journal.aavs/2017/5.11.436.445"]}, {"Citation": "Gao S., Yu B.-P., Li Y., Dong W.-G., Luo H.-S. Antiproliferative effect of octreotide on gastric cancer cells mediated by inhibition of Akt/PKB and telomerase. World J. Gastroenterol. 2003;9:2362. doi: 10.3748/wjg.v9.i10.2362.", "ArticleIdList": ["10.3748/wjg.v9.i10.2362", "PMC4656499", "14562414"]}, {"Citation": "Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique and specialized Applications. John Wiley & Sons; Hoboken, NJ, USA: 2015."}, {"Citation": "Al-Shammari A.M., Salman M.I., Saihood Y.D., Yaseen N.Y., Raed K., Shaker H.K., Ahmed A., Khalid A., Duiach A. In vitro synergistic enhancement of Newcastle Disease Virus to 5-fluorouracil cytotoxicity against tumor cells. Biomedicines. 2016;4:3. doi: 10.3390/biomedicines4010003.", "ArticleIdList": ["10.3390/biomedicines4010003", "PMC5344244", "28536371"]}, {"Citation": "Mullerad M., Bochner B.H., Adusumilli P.S., Bhargava A., Kikuchi E., Hui-Ni C., Kattan M.W., Chou T.-C., Fong Y. Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma. J. Urol. 2005;174:741\u2013746. doi: 10.1097/01.ju.0000164730.38431.5c.", "ArticleIdList": ["10.1097/01.ju.0000164730.38431.5c", "PMC1351159", "16006968"]}, {"Citation": "Franken N.A.P., Rodermond H.M., Stap J., Haveman J., Van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. 2006;1:2315\u20132319. doi: 10.1038/nprot.2006.339.", "ArticleIdList": ["10.1038/nprot.2006.339", "17406473"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "11"}, {"Year": "2022", "Month": "8", "Day": "30"}, {"Year": "2022", "Month": "9", "Day": "1"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "36"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["36144488", "PMC9506095", "10.3390/molecules27185757", "molecules27185757"]}}], "PubmedBookArticle": []}